Theratechnologies Inc. Cash Flow Reinvestment Rate

Latest as of May 2025: 3.81x

Theratechnologies Inc. cash flow reinvestment rate. Theratechnologies Inc. (TH) has a Cash Flow Reinvestment Rate of 3.81x as of May 2025, reinvesting CA$10.12 Million (capex CA$10.11 Million plus investments CA$-8.00K) from operating cash flow of CA$2.66 Million. Explore TH debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

3.81x
(Capex + Investments) / Operating CF

Total Reinvested

CA$10.12 Million
Capex + Investments

Operating Cash Flow

CA$2.66 Million
CAD

Capital Expenditures

CA$10.11 Million
CAD

Cash Flow Reinvestment Rate of Theratechnologies Inc. (2009–2024)

Cash flow reinvestment rate of Theratechnologies Inc. from 2009 to 2024. Historical reinvestment intensity for Theratechnologies Inc. across 6 annual periods. Explore TH capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Theratechnologies Inc. Cash Flow Reinvestment Rate by Year (2009–2024)

Theratechnologies Inc. cash flow reinvestment rate by year from 2009 to 2024. Year-by-year capital reinvestment analysis for Theratechnologies Inc.. For the full cash flow conversion analysis, see Theratechnologies Inc. (TH) cash conversion ratio.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2024 1.03x CA$2.44 Million CA$2.38 Million CA$1.50 Million ▼ -87.9%
2017 8.50x CA$16.21 Million CA$1.91 Million CA$73.82K ▲ +61.3%
2016 5.27x CA$10.55 Million CA$2.00 Million CA$1.19 Million ▲ +1080.7%
2015 0.45x CA$2.36 Million CA$5.30 Million CA$31.00K ▲ +211.7%
2010 0.14x CA$407.05K CA$2.84 Million CA$407.05K ▲ +98.9%
2009 0.07x CA$384.80K CA$5.35 Million CA$384.80K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow